Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid Nphenylamides in the treatment of pain

Details for Australian Patent Application No. 2008306207 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Rudolphi, Karl; Guehring, Hans; Michaelis, Martin

Agent Watermark

Pub. Number AU-A-2008306207

PCT Pub. Number WO2009/043495

Priority 61/015,256 20.12.07 US; 07019521.9 05.10.07 EP; 08013725.0 31.07.08 EP

Filing date 20 September 2008

Wipo publication date 9 April 2009

International Classifications

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/195 (2006.01)

A61K 31/635 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/043495 Priority application(s): WO2009/043495

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008306213-Rolling device and method for the operation thereof

2008306202-Crystalline EGFR - matuzumab complex and matuzumab mimetics obtained thereof